Jaws Acquisition Corp. (NYSE:JWS) announced in an 8-K filing this afternoon that its shareholders approved its combination with Cano Health at a special meeting earlier today.
The deal was overwhelmingly approved with 75.1% of shares participating in the vote, and the parties expect the transaction to close tomorrow June 3. Shares and warrants of combined entity are expected to begin trading on the NYSE on June 4 under the symbols “CANO” and “CANO.WS”, respectively.
Jaws did not share redemption figures in its filing, but they are unlikely to be significant as its shares closed at $14.51 on May 28, the day of its redemption deadline. This deal along with Deerfield (NASDAQ:DFHT)’s combination with fellow Medicare Advantage-focused CareMax have both been warmly received as Deerfield also closed at $14.50 today.
The first SPAC deal with a Medicare Advantage player of the past year – Social Capital III’s merger with Clover Health (NASDAQ:CLOV) – has fared less well, generally trading below $10 since late February. But, its performance includes external factors including a short seller report and regulatory probes.
Jaws and Cano initially announced their $4.4 billion deal on November 12. Cano serves more than 103,000 Medicare Advantage patients through 564 primary care physicians in Florida, Texas, Nevada, and Puerto Rico.
Most measures on the shareholders’ ballot passed by wide margins but some governance proposals were more controversial than others with one receiving 37.9% of votes against. For a full list of measures and vote tallies, click HERE.
ADVISORS
- Moelis & Company is acting as financial advisor to Cano Health.
- Credit Suisse is serving as financial advisor and exclusive capital markets advisor to Cano Health. Credit Suisse is also serving as exclusive placement agent on the private offering.
- Goodwin Procter LLP is serving as legal counsel to Cano Health and Cravath Swaine & Moore LLP is serving as counsel to certain shareholders, including members of Company management.
- Kirkland & Ellis LLP is serving as legal counsel to Jaws Acquisition Corp.
Solarius Capital (NASDAQ:INACU) has filed for a $150 million IPO to seek out a financial services target with a team making its first step into SPACs. The new SPAC is offering investors a 1/2 warrant in each unit and it will overfund its trust to 100.5% with $10.05 per unit in the trust account from...
At the SPAC of Dawn Today is a major day of economic indicators with eight different reads on retail sales, import prices, industrial production, as well as both business inventories and home builder confidence index rolling in through the morning. All of this is to come ahead of a Fed interest rate decision tomorrow. This...
Indigo (NASDAQ:INACU) has filed for a $100 million SPAC to take a first-time team on a broad search for a target as 2025 SPACs hit a key milestone. The new SPAC is to sell units containing one right to a 1/10 share in each with no overfunding of its trust. Shareholders are slated to get...
At the SPAC of Dawn SPAC votes are to heat up in a shortened week that is to see markets closed on Thursday. Teams have nonetheless put seven votes on the docket for the four days that business is in session. Only one of these is a vote to complete a business combination, which is...
Terms Tracker for the Week Ending June 13, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This week brought three new SPAC IPOs with pricings from BEST SPAC I Acquisition Corp., Blue Acquisition Corp. and Blue Water Acquisition Corp. III. All...